NCT04676555 Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple Sclerosis Status COMPLETED Phase N/A
NCT04675931 To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria Status COMPLETED Phase PHASE2
NCT04667949 Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients Status COMPLETED Phase PHASE4
NCT04667117 A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab Status COMPLETED Phase PHASE4
NCT04666298 Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C Status COMPLETED Phase PHASE2
NCT04666272 Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04666259 Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation Status COMPLETED Phase PHASE3
NCT04665154 A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04663997 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04662944 A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections Status COMPLETED Phase N/A
NCT04662931 An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients Status COMPLETED Phase PHASE4
NCT04659863 Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT04657822 Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study Status RECRUITING Phase PHASE4
NCT04656223 Digital Adherence Monitoring of Inhalative Therapy in Real- Life Conditions Status COMPLETED Phase N/A
NCT04652726 Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT04648930 Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies Status COMPLETED Phase N/A
NCT04645589 Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis Status COMPLETED Phase N/A
NCT04641442 Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations Status ACTIVE_NOT_RECRUITING Phase PHASE2